ASRS
AGIO icon

Arizona State Retirement System’s Agios Pharmaceuticals AGIO Stock Holding History

Arizona State Retirement System’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570K Buy
15,359
+198
+1% +$6.01K ﹤0.01% 1474
2026
Q1 		$513K Sell
15,161
-169
-1% -$4.79K ﹤0.01% 1444
2025
Q4 		$417K Sell
15,330
-925
-6% -$32.5K ﹤0.01% 1577
2025
Q3 		$652K Sell
16,255
-421
-3% -$15.8K ﹤0.01% 1360
2025
Q2 		$555K Buy
16,676
+1,978
+13% +$60K ﹤0.01% 1397
2025
Q1 		$431K Sell
14,698
-129
-0.9% -$4.28K ﹤0.01% 1496
2024
Q4 		$487K Buy
14,827
+114
+0.8% +$5.36K ﹤0.01% 1488
2024
Q3 		$654K Buy
14,713
+554
+4% +$25.2K ﹤0.01% 1346
2024
Q2 		$611K Sell
14,159
-1,201
-8% -$43.3K ﹤0.01% 1315
2024
Q1 		$449K Sell
15,360
-222
-1% -$5.95K ﹤0.01% 1503
2023
Q4 		$347K Sell
15,582
-243
-2% -$5.45K ﹤0.01% 1651
2023
Q3 		$392K Buy
15,825
+296
+2% +$7.83K ﹤0.01% 1515
2023
Q2 		$440K Buy
15,529
+1,201
+8% +$29.9K ﹤0.01% 1484
2023
Q1 		$329K Buy
14,328
+407
+3% +$10.8K ﹤0.01% 1652
2022
Q4 		$391K Buy
13,921
+521
+4% +$14.7K ﹤0.01% 1513
2022
Q3 		$379K Buy
13,400
+74
+0.6% +$1.99K ﹤0.01% 1489
2022
Q2 		$295K Buy
13,326
+114
+0.9% +$2.58K ﹤0.01% 1684
2022
Q1 		$385K Sell
13,212
-1,068
-7% -$32.6K ﹤0.01% 1640
2021
Q4 		$469K Sell
14,280
-815
-5% -$32.8K ﹤0.01% 1578
2021
Q3 		$697K Sell
15,095
-1,933
-11% -$93.4K 0.01% 1328
2021
Q2 		$938K Sell
17,028
-1,117
-6% -$62.5K 0.01% 1154
2021
Q1 		$937K Buy
18,145
+107
+0.6% +$5.3K 0.01% 1163
2020
Q4 		$782K Sell
18,038
-670
-4% -$26.5K 0.01% 1201
2020
Q3 		$655K Buy
18,708
+4,790
+34% +$210K 0.01% 1146
2020
Q2 		$744K Sell
13,918
-239
-2% -$11.1K 0.01% 914
2020
Q1 		$502K Buy
+14,157
New +$654K 0.01% 1000

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Arizona State Retirement System's AGIO Position: Q2 2026 in Review

Arizona State Retirement System increased its Agios Pharmaceuticals (AGIO) stake by 1.3% in Q2 2026, buying an estimated $6.01K and bringing the position to 15,359 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Arizona State Retirement System first reported a position in AGIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $938K in Q2 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Arizona State Retirement System held 15,359 shares of Agios Pharmaceuticals worth $570K as of Q2 2026.
  • Arizona State Retirement System bought 198 Agios Pharmaceuticals shares in Q2 2026, an estimated $6.01K.
  • Agios Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1474 holding.
  • Arizona State Retirement System first reported a position in Agios Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's Agios Pharmaceuticals position peaked at $938K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.